Serum N-Terminal Pro-B-Type Natriuretic Peptide Levels Are Associated With Functional Capacity in Patients With Peripheral Arterial Disease

被引:11
作者
Fan, Jin [1 ]
Jouni, Hayan [2 ]
Khaleghi, Mahyar [3 ]
Bailey, Kent R. [4 ]
Kullo, Iftikhar J. [1 ]
机构
[1] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Med, Rochester, MN 55905 USA
[3] Georgetown Univ Hosp, Washington Hosp Ctr, Dept Med, Washington, DC 20007 USA
[4] Mayo Clin, Dept Biomed Informat & Stat, Rochester, MN 55905 USA
基金
美国国家卫生研究院;
关键词
N-terminal pro-B-type natriuretic peptide; natriuretic peptides; functional capacity; peripheral arterial disease; ANKLE-BRACHIAL INDEX; INTERMITTENT CLAUDICATION; WALKING DISTANCE; WAVE REFLECTION; STIFFNESS; MANAGEMENT; ANGIOGENESIS; DIAGNOSIS; PROTEIN; TIME;
D O I
10.1177/0003319711423095
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
We hypothesized that higher serum levels of N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) are associated with lower functional capacity in patients with peripheral arterial disease ([PAD] n = 481, mean age 67, 68% men). Functional capacity was quantified as distance walked on a treadmill for 5 minutes. Patients were divided into 3 groups according to the distance walked: >144 yards (group 1, n = 254); 60 to 144 yards (group 2, n = 80); <60 yards or did not walk (group 3, n = 147). The association between NT-pro-BNP levels and the ordinal 3-level walking distance was assessed using multivariable ordinal logistic regression analyses that adjusted for several possible confounding variables. Higher levels of NT-pro-BNP were associated with a lower ordinal walking category independent of possible confounders (odds ratio [OR] 1.51, 95% confidence interval [CI] 1.28-1.77; P < .001). In conclusion, higher levels of NT-pro-BNP are independently associated with lower functional capacity in patients with PAD and may be a marker of hemodynamic stress in these patients.
引用
收藏
页码:435 / 442
页数:8
相关论文
共 43 条
[1]   RETRACTED: Ramipril reduces large-artery stiffness in peripheral arterial disease and promotes elastogenic remodeling in cell culture (Retracted Article) [J].
Ahimastos, AA ;
Natoli, AK ;
Lawler, A ;
Blombery, PA ;
Kingwell, BA .
HYPERTENSION, 2005, 45 (06) :1194-1199
[2]   RETRACTED: Reduced arterial stiffness may contribute to angiotensin-converting enzyme inhibitor induced improvements in walking time in peripheral arterial disease patients (Retracted article. See vol. 33, pg. 2552, 2015) [J].
Ahimastos, Anna A. ;
Dart, Anthony M. ;
Lawler, Adam ;
Blombery, Peter A. ;
Kingwell, Bronwyn A. .
JOURNAL OF HYPERTENSION, 2008, 26 (05) :1037-1042
[3]   Brachial-ankle pulse wave velocity is associated with walking distance in patients referred for peripheral arterial disease evaluation [J].
Amoh-Tonto, Comfort A. ;
Malik, A. Rauoof ;
Kondragunta, Venkateswarlu ;
Ali, Zeenat ;
Kullo, Iftikhar J. .
ATHEROSCLEROSIS, 2009, 206 (01) :173-178
[4]  
Anand Rishi G, 2007, Congest Heart Fail, V13, P319, DOI 10.1111/j.1527-5299.2007.07344.x
[5]   Effect of Simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and at one year after treatment [J].
Aronow, WS ;
Nayak, D ;
Woodworth, S ;
Ahn, C .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (06) :711-712
[6]   Critical issues in peripheral arterial disease detection and management - A call to action [J].
Belch, JJF ;
Topol, EJ ;
Agnelli, G ;
Bertrand, M ;
Califf, RM ;
Clement, DL ;
Creager, MA ;
Easton, JD ;
Gavin, JR ;
Greenland, P ;
Hankey, G ;
Hanrath, P ;
Hirsch, AT ;
Meyer, J ;
Smith, SC ;
Sullivan, F ;
Weber, MA .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (08) :884-892
[7]   Measures of arterial stiffness and wave reflection are associated with walking distance in patients with peripheral arterial disease [J].
Brewer, LaPrincess C. ;
Chai, High-Seng ;
Bailey, Kent R. ;
Kullo, Iftikhar J. .
ATHEROSCLEROSIS, 2007, 191 (02) :384-390
[8]   CARDIOVASCULAR ACTIONS OF ANF - CONTRIBUTIONS OF RENAL, NEUROHUMORAL, AND HEMODYNAMIC FACTORS IN SHEEP [J].
CHARLES, CJ ;
ESPINER, EA ;
RICHARDS, AM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (03) :R533-R538
[9]   Atrial natriuretic peptide-initiated cGMP pathways regulate vasodilator-stimulated phosphoprotein phosphorylation and angiogenesis in vascular endothelium [J].
Chen, Hongjie ;
Levine, Yehoshua C. ;
Golan, David E. ;
Michel, Thomas ;
Lin, Alison J. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (07) :4439-4447
[10]   Suboptimal control of atherosclerotic disease risk factors after cardiac and cerebrovascular procedures [J].
Cheng, Eric M. ;
Asch, Steve M. ;
Brook, Robert H. ;
Vassar, Stefanie D. ;
Jacob, Erin L. ;
Lee, Martin L. ;
Chang, Donald S. ;
Sacco, Ralph L. ;
Hsiao, An-Fu ;
Vickrey, Barbara G. .
STROKE, 2007, 38 (03) :929-934